A first-year dornase alfa treatment impact on clinical parameters of patients with cystic fibrosis: the Brazilian cystic fibrosis multicenter study

OBJECTIVE: To describe the clinical impact of the first year treatment with dornase alfa, according to age groups, in a cohort of Brazilian Cystic Fibrosis (CF) patients. METHODS: The data on 152 eligible patients, from 16 CF reference centers, that answered the medical questionnaires and performed...

Descripción completa

Detalles Bibliográficos
Autores principales: Rozov, Tatiana, Silva, Fernando Antônio A. e, Santana, Maria Angélica, Adde, Fabíola Villac, Mendes, Rita Heloisa
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Sociedade de Pediatria de São Paulo 2013
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4183036/
https://www.ncbi.nlm.nih.gov/pubmed/24473945
http://dx.doi.org/10.1590/S0103-05822013000400002

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4183036/
https://www.ncbi.nlm.nih.gov/pubmed/24473945
http://dx.doi.org/10.1590/S0103-05822013000400002

Ejemplares similares